2898 — Sunho Biologics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSmall Cap
- HK$968.20m
- HK$1.38bn
Annual cashflow statement for Sunho Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -52 | -133 |
| Depreciation | ||
| Non-Cash Items | 7.01 | 76.9 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 1.58 | 6.47 |
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -34.6 | -40.7 |
| Capital Expenditures | -1.44 | -1.03 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 0.077 | -82.9 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -1.36 | -83.9 |
| Financing Cash Flow Items | -0.456 | -3.48 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 27.1 | 255 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -8.84 | 123 |